Annual CFF
$145.14 M
NaN%
December 31, 2023
Summary
- As of February 7, 2025, RAPP annual cash flow from financing activities is $145.14 million
- RAPP annual CFF is now at all-time high.
Performance
RAPP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$1.39 M
-$160.75 M-100.87%
September 30, 2024
Summary
- As of February 7, 2025, RAPP quarterly cash flow from financing activities is -$1.39 million, with the most recent change of -$160.75 million (-100.87%) on September 30, 2024.
- Over the past year, RAPP quarterly CFF has dropped by -$65.05 million (-102.19%).
- RAPP quarterly CFF is now -100.87% below its all-time high of $159.35 million, reached on June 30, 2024.
Performance
RAPP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$221.48 M
-$86.75 M-28.15%
September 30, 2024
Summary
- As of February 7, 2025, RAPP TTM cash flow from financing activities is $221.48 million, with the most recent change of -$86.75 million (-28.15%) on September 30, 2024.
- Over the past year, RAPP TTM CFF has increased by +$72.69 million (+48.85%).
- RAPP TTM CFF is now -28.15% below its all-time high of $308.23 million, reached on June 30, 2024.
Performance
RAPP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RAPP Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -102.2% | +48.9% |
| 3 y3 years | - | -102.3% | +269.1% |
| 5 y5 years | - | -102.3% | +269.1% |
RAPP Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -100.9% | at low | -28.1% | +269.6% |
| 5 y | 5-year | at high | at low | -100.9% | at low | -28.1% | +269.6% |
| alltime | all time | at high | at low | -100.9% | at low | -28.1% | +269.6% |
Rapport Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.39 M(-100.9%) | $221.48 M(-28.1%) |
| Jun 2024 | - | $159.35 M(+150.3%) | $308.23 M(+107.2%) |
| Mar 2024 | - | $63.66 M(<-9900.0%) | $148.79 M(+2.5%) |
| Dec 2023 | $145.14 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | - | -$140.00 K(-100.2%) | $145.14 M(-0.1%) |
| Sep 2023 | - | $85.36 M(<-9900.0%) | $145.28 M(+142.5%) |
| Jun 2023 | - | -$90.00 K(-100.1%) | $59.92 M(-0.1%) |
| Mar 2023 | - | $60.01 M | $60.01 M |
FAQ
- What is Rapport Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly CFF year-on-year change?
- What is Rapport Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Rapport Therapeutics?
- What is Rapport Therapeutics TTM CFF year-on-year change?
What is Rapport Therapeutics annual cash flow from financing activities?
The current annual CFF of RAPP is $145.14 M
What is the all time high annual CFF for Rapport Therapeutics?
Rapport Therapeutics all-time high annual cash flow from financing activities is $145.14 M
What is Rapport Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of RAPP is -$1.39 M
What is the all time high quarterly CFF for Rapport Therapeutics?
Rapport Therapeutics all-time high quarterly cash flow from financing activities is $159.35 M
What is Rapport Therapeutics quarterly CFF year-on-year change?
Over the past year, RAPP quarterly cash flow from financing activities has changed by -$65.05 M (-102.19%)
What is Rapport Therapeutics TTM cash flow from financing activities?
The current TTM CFF of RAPP is $221.48 M
What is the all time high TTM CFF for Rapport Therapeutics?
Rapport Therapeutics all-time high TTM cash flow from financing activities is $308.23 M
What is Rapport Therapeutics TTM CFF year-on-year change?
Over the past year, RAPP TTM cash flow from financing activities has changed by +$72.69 M (+48.85%)